Pulmonary Diseases Completed Phase 1 Trials for Ciprofloxacin (DB00537)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01052298Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)Treatment